Cargando…

Effects of complement and serum IgG on rituximab-dependent natural killer cell-mediated cytotoxicity against Raji cells

Accumulating evidence indicates that the anti-CD20 monoclonal antibody rituximab significantly improves the clinical prognosis of patients with non-Hodgkin lymphoma and chronic lymphocytic leukemia. However, a number of patients relapse or fail to respond to rituximab. To further understand the caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Huang, Ke, Liu, Ling, Qu, Yuhua, Huang, Yan, Wu, Yanfeng, Wei, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313095/ https://www.ncbi.nlm.nih.gov/pubmed/30655772 http://dx.doi.org/10.3892/ol.2018.9630

Ejemplares similares

Low pH impairs complement-dependent cytotoxicity against IgG-coated target cells
por: Dantas, Ezequiel, et al.
Publicado: (2016)

Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021)

Rituximab-induced IgG hypogammaglobulinemia in children with nephrotic syndrome and normal pre-treatment IgG values
por: Marzuillo, Pierluigi, et al.
Publicado: (2019)

Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis
por: Wallwork, Rachel, et al.
Publicado: (2018)

Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro
por: Könitzer, Jennifer D., et al.
Publicado: (2015)

Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease
por: Schulte, Lucas A., et al.
Publicado: (2020)

Cutoff Values of Serum IgG4 and Histopathological IgG4+ Plasma Cells for Diagnosis of Patients with IgG4-Related Disease
por: Masaki, Yasufumi, et al.
Publicado: (2012)

IgG N-glycosylation from Patients with Pemphigus Treated with Rituximab
por: Font, Guillaume, et al.
Publicado: (2022)

Serum total IgG and IgG4 levels in thyroid eye disease
por: Sy, Aileen, et al.
Publicado: (2016)

Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
por: Zhao, JianGuo, et al.
Publicado: (2023)

Carbamylation reduces the capacity of IgG for hexamerization and complement activation
por: Lubbers, R., et al.
Publicado: (2020)

Factors affecting IgG4-mediated complement activation
por: Oskam, Nienke, et al.
Publicado: (2023)

Serum IgG and lymphocyte counts are useful for the early detection of infection in patients receiving bendamustine-rituximab therapy
por: Suzuki, Manabu, et al.
Publicado: (2022)

Refractory IgG4-related intracranial hypertrophic pachymeningitis responded to rituximab
por: Liao, Bing, et al.
Publicado: (2014)

IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia
por: Schmidt, David E., et al.
Publicado: (2020)

Successful treatment of IgG4‐related hypertrophic pachymeningitis with induction rituximab and dexamethasone followed by maintenance rituximab
por: Seegobin, Karan, et al.
Publicado: (2021)

The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto’s Thyroiditis: An in Vitro Model of Thyroid Autoimmunity
por: Ząbczyńska, Marta, et al.
Publicado: (2020)

The protective effects of antigen-specific IgY on pyocyanin-treated human lymphoma Raji cells
por: Susilowati, Heni, et al.
Publicado: (2019)

Detection of serum IgM and IgG for COVID-19 diagnosis
por: Zhong, Ling, et al.
Publicado: (2020)

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children
por: BAYRAM, Rumeysa Olcay, et al.
Publicado: (2019)

Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways
por: Lilienthal, Gina-Maria, et al.
Publicado: (2018)

Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab
por: Nedosekin, Dmitry, et al.
Publicado: (2021)

Diagnostic Performance of Serum IgG4 Levels in Patients With IgG4-Related Disease
por: Yu, Kuang-Hui, et al.
Publicado: (2015)

Serum checkpoint molecules in patients with IgG4-related disease (IgG4-RD)
por: Matsumoto, Haruki, et al.
Publicado: (2021)

Regulation of antibody-mediated complement-dependent cytotoxicity by modulating the intrinsic affinity and binding valency of IgG for target antigen
por: Wang, Bo, et al.
Publicado: (2019)

Serum IgG Subclasses in Autoimmune Diseases
por: Zhang, Haoze, et al.
Publicado: (2015)

Reference Intervals for Serum Immunoglobulins IgG, IgA, IgM and Complements C3 and C4 in Iranian Healthy Children
por: Kardar, GA, et al.
Publicado: (2012)

Small-Angle X-ray Scattering Screening Complements Conventional Biophysical Analysis: Comparative Structural and Biophysical Analysis of Monoclonal Antibodies IgG1, IgG2, and IgG4
por: Tian, Xinsheng, et al.
Publicado: (2014)

Rituximab treatment for isolated IgG4-related hypophysitis in a teenage female
por: Bullock, Danielle R, et al.
Publicado: (2018)

Increased serum IgG4 levels and intimal IgG4-positive cell infiltration in rapidly growing aortic aneurysm
por: Fujita, Shuichi, et al.
Publicado: (2013)

The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain
Publicado: (1991)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

Changes of serum IgG glycosylation patterns in rheumatoid arthritis
por: Deng, Xiaoyue, et al.
Publicado: (2023)

The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)

Detection of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders
por: Su, Yuying, et al.
Publicado: (2015)

Salivary IgG levels in neonatal calves and its association to serum IgG: an observational pilot study
por: Johnsen, Julie Føske, et al.
Publicado: (2019)

Complement-independent bystander injury in AQP4-IgG seropositive neuromyelitis optica produced by antibody-dependent cellular cytotoxicity
por: Duan, Tianjiao, et al.
Publicado: (2019)

Serum IgA, IgM, and IgG responses in COVID-19
por: Ma, Huan, et al.
Publicado: (2020)

A Role for Complement in Feedback Enhancement of Antibody Responses by IgG3
por: de Ståhl, Teresita Díaz, et al.
Publicado: (2003)

Complement Activation Selectively Potentiates the Pathogenicity of the IgG2b and IgG3 Isotypes of a High Affinity Anti-Erythrocyte Autoantibody
por: da Silveira, Samareh Azeredo, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_006h7l9qv6h0kvdmna1ahlucs8